As part of our ongoing coverage of major gatherings in the nucleic acid therapeutics space, Nucleic Acid Insights presents a preview of the RNAi-Based Therapeutics Summit 2026. Taking place January 27–29, 2026, in Boston, Massachusetts, the summit will convene stakeholders from across the RNA interference (RNAi) ecosystem to examine how small interfering RNA (siRNA) and microRNA therapeutics are progressing beyond established hepatic indications toward broader systemic and extrahepatic applications. Against a backdrop of recent regulatory approvals, late-stage clinical advances, and major strategic partnerships, the meeting will focus on translating RNAi innovation into durable clinical and commercial success. With a strong emphasis on delivery technologies, novel chemistries, and emerging disease areas, the summit provides a forum to address the scientific and operational challenges that continue to shape RNAi development.
No author supplied (Fri,) studied this question.